Combination of low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical hodgkin lymphoma (rrhl), 5-year experience from tata memorial centre - Aditya Narayan; Shyam Srinivasan; Poonam Khemani; Nidhi Dhariwal; Akanksha Chichra; Chetan Dhamne; Nirmalya Roy Moulik; Gaurav Narula; Sneha Shah; Tanuja Seth; VikramjitKhanwar; Shripad Banavalli (Elsevier, 2024)